Abirame Sivakumar

Ms. Abirame Sivakumar

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
Vindya PathirajaVindya Pathiraja
Vindya Pathiraja
TMTharanga Mudalige
Tharanga Mudalige
LDLanka Dasanyake
Lanka Dasanyake
NRNirmala Rathnayake
Nirmala Rathnayake
SESohier Elneil
Sohier Elneil
Women-led indigenous farming and ethnobotanical systems across Asia, Africa, and South America are vital yet often overlooked foundations for reproductive health, food security, and ecological resilience. This paper draws on diverse case studies—including jamu in Indonesia, ayurveda in India and helawedakama in Sri Lanka, milpa systems in Mexico, Andean potato terraces, and sub-Saharan African agroforestry—to illustrate how women cultivate biodiversity-rich agricultural and medicinal traditions that support menstruation, fertility, childbirth, and postpartum care.As farmers, healers, seed custodians, and knowledge holders, women advance nutritional, therapeutic, and psychosocial outcomes while preserving intergenerational resilience. Yet these systems face mounting threats from land dispossession, extractive industries, commercial seed regimes, and exclusionary policies. Regional examples—from Kenya’s seed banks and Brazil’s feminist agroecology to Venezuela’s survival-based herbal practices—demonstrate both the strength of these traditions and the gendered barriers to their sustainability.Climate change further underscores the urgency of safeguarding these low-input, locally adapted practices. As women increasingly navigate civil society and state frameworks, their knowledge must be formally recognized and resourced. We argue that inclusive health, agricultural, and environmental policies that centre gender equity, biocultural heritage, and climate resilience in low- and middle-income countries. International collaboration is essential to protecting and scaling women-led indigenous systems as pathways toward transformative global health and sustainability.

27 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
SESohier Elneil
Sohier Elneil
Abirame SivakumarAbirame Sivakumar
Abirame Sivakumar
Om KurmiOm Kurmi
Om Kurmi
Vindya PathirajaVindya Pathiraja
Vindya Pathiraja
George Uchenna ElejeGeorge Uchenna Eleje
George Uchenna Eleje
Reproductive politics lie at the intersection of gender, power, and governance, shaping women's autonomy through laws, policies, and cultural norms. Historically, colonialism and population control initiatives marginalized women, particularly in the Global South, fostering distrust in healthcare systems. Feminist movements advocate for reproductive justice, yet economic and nationalistic interests continue to influence access to care.Governments regulate reproduction to control demographics, labor markets, and national power. Pronatalist and antinatalist policies, such as China’s One-Child Policy, have led to coercive interventions, disproportionately affecting marginalized communities. Reproductive politics also shape masculinity, fatherhood, and state-controlled family structures.Global reproductive policies reflect ideological struggles, from restrictive abortion laws in Poland and the U.S. to progressive approaches in Nepal and Vietnam. Socioeconomic barriers further limit access to contraception, maternal healthcare, and fertility treatments. Achieving reproductive justice requires inclusive policies, healthcare reform, and recognition of reproductive rights as fundamental to gender equality.

7 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
Abirame SivakumarAbirame Sivakumar
Abirame Sivakumar
Mohammad HaddadiMohammad Haddadi
Mohammad Haddadi
OKOm Kurmi
Om Kurmi
PPPeter Phiri
Peter Phiri
SESohier Elneil
Sohier Elneil
The advancement of global health equality is being hindered by persistent disparities in women's health data. Despite comprising over half of the global population, women remain underrepresented or poorly characterized in many health datasets. According to the Gender Data Outlook (GDO) Index, developed by PARIS21 and UN Women, while progress has been made, systemic barriers continue to obstruct comprehensive gender data collection and dissemination. The index shows that even in high-income countries like Japan and the United Kingdom, strong data production exists, but institutional gaps and coordination issues persist. This issue is further exacerbated in low- and middle-income countries (LMICs).Key areas such as menstrual and reproductive health, aging, and gender-based differences in both non-communicable and communicable diseases are often overlooked or insufficiently disaggregated by sex, gender, age, ethnicity, and geography (Figure 1). This lack of inclusive data leads to diagnostic delays, ineffective treatments, and policies that fail to reflect women’s realities. Bias is further intensified by the underrepresentation of intersectional factors such as gender identity, socio-economic status, and disability, making health systems less responsive to women’s needs, especially in underserved populations.To address these gaps, investments in gender-sensitive, community-driven data systems, equitable research funding, and ethical data governance are essential. Improving women's health data is not only crucial for research but is also a matter of justice, critical to achieving the Sustainable Development Goals (SDGs). Currently, countries lack 44% of the data needed to track 51 gender-related SDG indicators, including SDG-5 on gender equality. Without urgent action, global health initiatives risk exacerbating disparities rather than improving them. As the 2030 deadline for the SDGs approaches rapidly, it is our responsibility to take the necessary actions to close gender data gaps.

16 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
Abirame SivakumarAbirame Sivakumar
Abirame Sivakumar
Vindya PathirajaVindya Pathiraja
Vindya Pathiraja
NRNirmala Rathnayake
Nirmala Rathnayake
Om KurmiOm Kurmi
Om Kurmi
SESohier Elneil
Sohier Elneil
Despite institutional commitments to equality, diversity and inclusion, women, particularly those from ethnic minority backgrounds, remain underrepresented in senior academic positions in the United Kingdom. This critical appraisal examines structural and cultural barriers to equitable career progression, with particular attention to clinical academics balancing research, teaching and patient care. Drawing on published literature and workforce statistics, it discusses opaque promotion criteria, unequal funding opportunities, limited mentorship, caregiving responsibilities, racism and the undervaluation of clinical contributions and unpaid diversity work. These intersecting disadvantages are compounded by insecure career pathways and competing institutional demands. Lessons from National Health Service initiatives highlight potential approaches to improving transparency, mentorship and accountability. The paper proposes integrated career pathways, explicit promotion criteria, targeted sponsorship, recognition of invisible labour and measurable institutional equity targets. Research should capture ethnic minority women’s lived experiences and evaluate interventions. Sustainable progress requires structural reform supported by institutional accountability and cultural change.

6 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
Vindya PathirajaVindya Pathiraja
Vindya Pathiraja
TMTharanga Mudalige
Tharanga Mudalige
LDLanka Dasanyake
Lanka Dasanyake
NRNirmala Rathnayake
Nirmala Rathnayake
SESohier Elneil
Sohier Elneil
Bladder prolapse, also known as cystocoele, is the most common form of pelvic organ prolapse (POP), significantly affecting women's physical, sexual, and psychosocial health, particularly in low- and middle-income countries (LMICs). Despite its widespread prevalence and disabling consequences, bladder prolapse remains under-recognised and inadequately addressed in global health strategies. Prevalence estimates vary widely across regions, from 3% to 64.6%, influenced by diagnostic methods and cultural reporting biases. Common risk factors include high parity, early childbirth, prolonged labour, poor postpartum care, malnutrition, obesity, and ageing. Clinical diagnosis often relies on simplified grading systems in resource-limited settings. Conservative treatments like pelvic floor muscle training and pessary use are underutilised due to lack of staff training, and cultural barriers. Surgical management, primarily native tissue anterior repair, is often inaccessible or inconsistently performed. Key challenges include sociocultural stigma, lack of epidemiological data, inadequate provider training, and limited access to specialised care. Bladder prolapse remains a hidden burden in LMICs due to structural, sociocultural, and health system gaps. Addressing it requires integrating prolapse screening into routine maternal care, expanding conservative management, training healthcare providers, reducing stigma, and investing in locally relevant research and national guidelines. Here, we argue for evidence-based practices in LMICs to improve our understanding through epidemiology, risk factors, clinical presentation, diagnostic practices, treatment approaches, and sociocultural barriers. Elevating bladder prolapse as a public health and gender equity issue can improve health outcomes and quality of life for millions of women in Africa, Asia, and the Middle East.

8 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
IAIeera Aggarwal
Ieera Aggarwal
Vindya PathirajaVindya Pathiraja
Vindya Pathiraja
George Uchenna ElejeGeorge Uchenna Eleje
George Uchenna Eleje
TTTeck-Hock Toh
Teck-Hock Toh
PPPeter Phiri
Peter Phiri
Background: Menopause affects more than one billion individuals worldwide, yet outcome measurement in research remains narrow, inconsistent, and largely focused on vasomotor and genitourinary symptoms. Existing frameworks do not adequately capture the broader functional and psychosocial impacts reported by patients. We aimed to develop and validate a global Core Patient-Reported Outcome Set for Menopause (cPRO-MARiE) using prospective mixed-methods data from thirteen countries. Methods: We analysed quantitative data from 5,228 participants and qualitative interviews from 302 individuals across thirteen countries spanning diverse socio-cultural and health-system contexts. Validated instruments assessed symptom severity, psychological wellbeing, cognitive function, sleep disturbance, pain and somatic symptoms, and functional outcomes. Qualitative data underwent reflexive thematic analysis guided by the Delanerolle–Phiri framework. A COMET-aligned process integrating quantitative severity patterns, qualitative thematic convergence, cross-country reproducibility, psychometric validation and equity considerations was applied to derive the core outcome set. Findings: Seven domains were consistently identified across all settings: sleep disturbance; psychological wellbeing; cognitive function; pain and somatic symptoms; vasomotor symptoms; genitourinary and sexual health; and social, relational and occupational functioning. These domains demonstrated conceptual stability, cross-country reproducibility and psychometric coherence and were strongly linked to functional impact. The resulting cPRO-MARiE specifies mandatory Tier 1 patient-reported outcomes within each domain, with Tier 2 outcomes retained for context-specific and equity-focused research. Interpretation: cPRO-MARiE is the first empirically derived, globally validated core outcome set for menopause. By capturing symptom domains and functional impacts prioritised by patients across diverse settings, it provides a robust and clinically meaningful framework for outcome measurement in research, routine care, and health-system evaluation.